Adore is the first cloud based smart system with custom-developed algorithm powered by Artificial Intelligence (AI) and Machine Learning (ML) engine to provide real time health assessment and management via mobile apps and devices.

During a recent interview, Saeed Azimi, CEO of DynoSense, made these comments: “With Adore, we offer comprehensive analysis of the body composition. With this product we also offer education and understanding of what it means to have improved body balance and how to achieve it. Our patented design has slick edges, infused and bright display screen, improved foot sensors, light weight, durable, humidity resistant, and easy to clean. AI/ML cloud software and social networking are big part of this unique solution.”

He goes on to say: “We have a network of medical advisors and most of our team members are physically active individuals and they are into understanding and learning what people need to do to improve their health conditions. The team is well experienced, with extensive backgrounds in high tech of various disciplines (Software Engineers, EE, ME, Analytical Engineers, Nutritionist, Medical Doctors), and comprised of some of the brightest people in Silicon Valley.”

DynoSense has launched a crowdfunding campaign on Kickstarter to bring awareness to this phenomenal product and support from early adopters to take Adore to the next level. Sponsors will receive great perks and be part of the birth of a whole new generation of personal health products.

About DynoSense Corp.

Based in San Jose, Calif., DynoSense Corp. is a digital health innovator founded in 2013. The company’s vision is to be a leading force behind the digital healthcare revolution. Its mission is to inspire better health and deliver breakthrough products and services that are integrated, accurate, secure and simple to use. Adore is one the first products by DynoSense on Kickstarter. DynoSense is supported by a network of renowned medical advisors – Dr. Steven Steinhubl, Chief Medical  Advisor of DynoSense, Director of Digital Medicine, Scripps Translational Science Institute is one such notable figure. DynoSense closed a Series-A funding of $9.4M in April 2015 and is currently in the process of raising Series-B round of $10M. The company has already raised $4M of the $10M and is recognized by Silicon Valley Chamber of Commerce as the most innovative health company in 2016. It has over 17 patent applications and growing.

For more information on DynoSense and its products, please visit:  www.dynosense.com